Mirati - oncology?

[anonymous]

The head of HR is the devil. She lies, cheats, and throws anyone under the bus to protect the company. Stay away

The GC is a nightmare loser along with the rest of the exec team. They had a decent crew when they started, but fired them all and brought in this bunch of losers. $69 share says it all. LMAO

 

[anonymous]

Stay away from this dumpster fire. You’ve been warned.

 

[anonymous]

I concur with the Asian HR lady being a Biaach! She has a chip on her shoulder. She makes our company look bad.

 

[anonymous]

2/3 of stock value lost since Meek joined. Where the hell is the board?

 

[anonymous]

2/3 of stock value lost since Meek joined. Where the hell is the board?

Asleep

 

[anonymous]

Gentlemen, it has been a privilege playing with you tonight...

 

[anonymous]

Gentlemen, it has been a privilege playing with you tonight...

LOL. Were you short this? Man what a bloodbath, trading at 2018 prices. I don’t think they even dosed the first patient in 2018 and the SP is the same with a pending approval. Unreal.

 

[anonymous]

LOL. Were you short this? Man what a bloodbath, trading at 2018 prices. I don’t think they even dosed the first patient in 2018 and the SP is the same with a pending approval. Unreal.

Of course. The drug will never be approved. Serious AEs in 43% of patients.

 

[anonymous]

Meek is as Meek does.

 

[anonymous]

Boy, that guy who predicted $45 a share a while back is looking pretty damn prophetic.

yes he is. This is bad bad bad….

 

[anonymous]

Gee…similar efficacy, greater toxicity…umm where did I read that before on this thread?

Very well may get approved, however it will get off the ground.

I also told you that on here…

 

[anonymous]

Meeks will sell his mother for a pasta meal. He is the most non loyal to his people you will find.
At ipsen he was like a mob boss. So funny the fergene thing went belly up.

Fergene 2.0

 

[anonymous]

i predicted $48 but I’m way off. it’s $39 and soon $20s in a few weeks.

 

[anonymous]

Why would anyone stick around to 1/see if this thing sees the light of day and 2/have any desire to launch this toxic drug?

 

[anonymous]

Why would anyone stick around to 1/see if this thing sees the light of day and 2/have any desire to launch this toxic drug?

 

[anonymous]

The stock should take another pounding at ASCO. Similar efficacy / more grade 3/4 than competition? Amgen vs. none player. That’s when you buy the stock. If the CCO leaves dump everything. It’s not his first rodeo. Most assuredly gets approval by Xmas (PDUFA).

 

[anonymous]

The stock should take another pounding at ASCO. Similar efficacy / more grade 3/4 than competition? Amgen vs. none player. That’s when you buy the stock. If the CCO leaves dump everything. It’s not his first rodeo. Most assuredly gets approval by Xmas (PDUFA).

 

[anonymous]

It is the CCO’s first rodeo. He is out of his depth, insecure micromanager who hired an equally incompetent leader who blew launches in Europe and has zero experience in the US.

They would not be able to compete even if the drug was better.

A mass exodus is coming very soon. People were leaving before the stock crash - culture at the entire company is v toxic.

The stock should take another pounding at ASCO. Similar efficacy / more grade 3/4 than competition? Amgen vs. none player. That’s when you buy the stock. If the CCO leaves dump everything. It’s not his first rodeo. Most assuredly gets approval by Xmas (PDUFA).

 

[anonymous]

The boards hired meek to do what he is doing. No confidence in the E team - running the company into the ground.
I smell lawsuits.

QUOTE="anonymous, post: 6675938"]When does the board wake up and fire Meek?[/QUOTE]

 

[anonymous]

The boards hired meek to do what he is doing. No confidence in the E team - running the company into the ground.
I smell lawsuits.

Fire Meek’s bloated ass.